FREDUN PHARMACEUTICALS
Smallcap | BSE
Sector
Here's the live share price of Fredun Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
3.06₹ 77.40
As on Jun 17, 2026, 04:01 PM IST
Source: Dion Global
Fredun Pharmaceuticals Price Performance
Today's LowToday's High
₹2,539.95₹2,699.00
₹2,610.15
52 Weeks' Low52 Weeks' High
₹791.00₹2,699.00
₹2,610.15
Open Price
₹2,540.00
Prev. Close
₹2,532.75
Volume
15,725
Source: Dion Global
Fredun Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Fredun Pharmaceuticals | 16.03 | 13.36 | 61.62 | 60.59 | 220.52 | 44.27 | 43.79 |
| Sun Pharmaceutical Industries | 1.43 | -4.47 | 2.32 | 4.27 | 10.46 | 22.04 | 22.32 |
| Divi's Laboratories | 0.13 | -2.53 | 8.39 | 4.38 | 1.87 | 22.95 | 9.14 |
| Torrent Pharmaceuticals | -2.69 | 1.19 | 3.62 | 18.28 | 37.82 | 33.77 | 24.67 |
| Cipla | -2.52 | -5.50 | 6.30 | -10.07 | -10.03 | 10.05 | 7.23 |
| Zydus Lifesciences | -3.77 | 7.34 | 18.39 | 16.43 | 11.09 | 24.28 | 11.40 |
| Dr. Reddy's Laboratories | -0.47 | -4.69 | -1.95 | -0.83 | -3.33 | 9.19 | 3.71 |
| Lupin | -0.32 | 0.61 | -1.55 | 7.01 | 16.03 | 40.05 | 14.29 |
| Mankind Pharma | -0.41 | -5.38 | 12.35 | 10.21 | 0.33 | 11.49 | 10.65 |
| Aurobindo Pharma | -2.86 | -5.29 | 12.07 | 17.55 | 28.47 | 28.04 | 8.11 |
| Laurus Labs | -1.55 | 3.15 | 39.26 | 34.85 | 106.35 | 55.43 | 17.51 |
| Biocon | -1.27 | -3.44 | 7.64 | 4.93 | 20.27 | 18.90 | 0.63 |
| Alkem Laboratories | 0.62 | -2.50 | -0.26 | -3.32 | 11.03 | 16.16 | 10.99 |
| Glenmark Pharmaceuticals | -0.10 | -8.47 | -2.02 | 9.59 | 29.04 | 49.54 | 27.36 |
| Abbott India | -0.27 | -6.89 | -1.12 | -6.71 | -17.47 | 4.07 | 9.49 |
| Anthem Biosciences | -1.44 | -2.70 | 18.58 | 14.91 | 5.24 | 1.72 | 1.03 |
| Ipca Laboratories | -4.28 | -6.21 | 0.12 | 9.48 | 13.33 | 28.43 | 8.77 |
| Ajanta Pharma | -2.55 | -4.70 | 0.14 | 17.65 | 18.60 | 27.57 | 18.44 |
| GlaxoSmithKline Pharmaceuticals | 4.39 | -8.13 | -9.86 | -14.00 | -33.18 | 15.77 | 7.30 |
| Gland Pharma | -4.73 | 1.73 | 32.05 | 31.85 | 26.71 | 28.98 | -6.67 |
Source: Dion Global
Over the last one year, Fredun Pharmaceuticals has gained 220.52% compared to peers like Sun Pharmaceutical Industries (10.46%), Divi's Laboratories (1.87%), Torrent Pharmaceuticals (37.82%). From a 5 year perspective, Fredun Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (22.32%) and Divi's Laboratories (9.14%).
Fredun Pharmaceuticals Financials
Source: Dion Global
Fredun Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,346.18 | 2,457.84 |
| 10 | 2,327.53 | 2,404.74 |
| 20 | 2,378.33 | 2,371.12 |
| 50 | 2,214.23 | 2,229.84 |
| 100 | 1,926.44 | 2,030.15 |
| 200 | 1,733.18 | 1,759.5 |
Source: Dion Global
Fredun Pharmaceuticals Share Holding Pattern
In the latest quarter, Fredun Pharmaceuticals saw a rise in promoter holding to 44.57%, while DII stake decreased to 2.81%, FII holding unchanged at 1.06%, and public shareholding moved down to 51.56% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fredun Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Jun 13, 2026, 12:59 AM IST IST | Fredun Pharma. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Jun 11, 2026, 12:33 AM IST IST | Fredun Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Jun 09, 2026, 01:27 AM IST IST | Fredun Pharma. - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 20 |
| Jun 09, 2026, 01:07 AM IST IST | Fredun Pharma. - Intimation Of Record Date For The Purpose Of Final Dividend For The Financial Year 2025-26 |
| Jun 09, 2026, 01:03 AM IST IST | Fredun Pharma. - Notice Of Book Closure For The Purpose Of 39Th Annual General Meeting (AGM). |
Source: Dion Global
About Fredun Pharmaceuticals
Fredun Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 08/06/1987 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1987PLC043662 and registration number is 043662. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 635.47 Cr. and Equity Capital is Rs. 5.47 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- AddressURMI ESTATE, Mumbai Maharashtra 400013
- Contact
Source: Dion Global
Management
- Dr.(Mrs.) Daulat N MedhoraChairman & Jt. M. D
- Mr. Fredun MedhoraManaging Director & CFO
- Mrs. Daisy D�souzaInd. Non-Executive Director
- Mr. Anshu AgarwalInd. Non-Executive Director
- Mrs. Sonal DesaiInd. Non-Executive Director
- Ms. Pooja Narendra SanghaviInd. Non-Executive Director
FAQs on Fredun Pharmaceuticals Share Price
What is the share price of Fredun Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Fredun Pharmaceuticals is ₹2,610.15 as on Jun 17, 2026.
What kind of stock is Fredun Pharmaceuticals?
The Fredun Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Fredun Pharmaceuticals?
The market cap of Fredun Pharmaceuticals is ₹1,438.89 Cr as on Jun 17, 2026.
What are today's High and Low prices of Fredun Pharmaceuticals?
Today’s highest and lowest price of Fredun Pharmaceuticals are ₹2,699.00 and ₹2,539.95.
What are the 52 Week High and 52 Week Low of Fredun Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Fredun Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Fredun Pharmaceuticals is ₹2,699.00 and 52-week low of Fredun Pharmaceuticals is ₹791.00 as on Jun 17, 2026.
How has the Fredun Pharmaceuticals performed historically in terms of returns?
The Fredun Pharmaceuticals has shown returns of 3.06% over the past day, 13.36% for the past month, 59.42% over 3 months, 212.71% over 1 year, 44.27% across 3 years, and 43.79% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Fredun Pharmaceuticals?
P/E ratio of and PB ratio of Fredun Pharmaceuticals are 38.42 and 5.45 on Jun 17, 2026. While the company gives a dividend yield of 0.03 per annum.
Source: Dion Global
✕